Nalagenetics
Insights
Investing in health tech to tackle Indonesia’s greatest challenges
The COVID-19 pandemic has exposed critical gaps in Indonesia’s healthcare infrastructure, revealing structural and systemic shortcomings requiring scalable solutions. Change doesn’t happen overnight, particularly for the healthcare sector, which consists of multiple intertwined industries with strict regulatory oversight. But because the industry is highly regulated,…
Insights
What’s next in Indonesia’s healthcare landscape: Digital transformation, preventive care, and early detection
The Indonesian healthcare landscape has improved significantly in the past decade. It has strengthened access to funding through the successful rollout of the BPJS Kesehatan, or universal healthcare, and the successful reforms implemented through the Omnibus Law that we will see in the coming years.…
Press Release
East Ventures and NalaGenetics’ commitment to supporting genomic sample analysis at the Biomedical and Genome Science Initiative (BGSi)
East Ventures, a pioneering and leading venture capital (VC) firm in Indonesia and Southeast Asia, and NalaGenetics, a biotechnology company focused on personalized medicine, diet, and screening, has signed a Memorandum of Understanding (MoU) with Director General of Health Services, Ministry of Health of the…
From Portfolios
Genetic testing: Leading the way in preventive care for Southeast Asia
In a region plagued by diseases such as heart disease, stroke, cancer, diabetes and neonatal deaths, NalaGenetics is taking a stand. As a prominent provider of genetic testing solutions, this pioneering company is on a mission to combat these ailments and improve patient outcomes in…
Press Release
East Ventures launched a white paper on genomics in collaboration with the Ministry of Health of the Republic of Indonesia
East Ventures, a pioneering sector-agnostic venture capital firm that has supported over 250 tech companies across Southeast Asia, today launched a white paper “Genomics: Leapfrogging into the Indonesian healthcare future”. This white paper is presented by East Ventures in collaboration with the Ministry of Health…
Insights
Why Indonesia should embrace genomics now
In 2013, Angelina Jolie, a Hollywood movie star and filmmaker, made a brave medical choice to remove both breasts as a preventive measure. She had another prophylactic surgery to remove her ovaries and fallopian tubes in the next couple of years. The decision was made…
Insights
Indonesian Health System Transformation
On 25 October 2022, East Ventures moderated a Fireside Chat with the Indonesian Minister of Health, Budi G. Sadikin at the Embassy of the Republic of Indonesia in Singapore. The session was attended by Singaporean health sector private players, Indonesian businesses, and the Indonesian diaspora…
Insights
Indonesia’s Health & Biotechnology Investment Opportunities
During the East Ventures Summit 2022, Budi Gunadi Sadikin, Indonesian Minister of Health, was invited to become our keynote speaker, who presented his few insights on Indonesia’s Health & Biotechnology Investment Opportunities. According to Mr. Budi, two major issues are happening in Indonesia’s healthcare sector:…
Insights
Rising biotech innovations to address Indonesia’s healthcare problems
With an over 270 million population, Indonesia remains an emerging medical market, supported by the surge of healthcare awareness demanded by the rising middle-income community. However, the country has faced chronic problems as the pandemic unveils shortcomings and an elevated sense of urgency to develop…